These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 28204519)

  • 1. Cost-effectiveness of 'immediate IVF' versus 'delayed IVF': a prospective study.
    Eijkemans MJC; Kersten FAM; Lintsen AME; Hunault CC; Bouwmans CAM; Roijen LH; Habbema JDF; Braat DDM
    Hum Reprod; 2017 May; 32(5):999-1008. PubMed ID: 28204519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
    Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
    Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of lifestyle intervention in obese infertile women.
    van Oers AM; Mutsaerts MAQ; Burggraaff JM; Kuchenbecker WKH; Perquin DAM; Koks CAM; van Golde R; Kaaijk EM; Schierbeek JM; Klijn NF; van Kasteren YM; Land JA; Mol BWJ; Hoek A; Groen H;
    Hum Reprod; 2017 Jul; 32(7):1418-1426. PubMed ID: 28486704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?
    van Eekelen R; Eijkemans MJ; Mochtar M; Mol F; Mol BW; Groen H; van Wely M
    Hum Reprod; 2020 Sep; 35(9):2037-2046,. PubMed ID: 32876323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
    Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
    Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF.
    van Heesch MM; van Asselt AD; Evers JL; van der Hoeven MA; Dumoulin JC; van Beijsterveldt CE; Bonsel GJ; Dykgraaf RH; van Goudoever JB; Koopman-Esseboom C; Nelen WL; Steiner K; Tamminga P; Tonch N; Torrance HL; Dirksen CD
    Hum Reprod; 2016 Nov; 31(11):2527-2540. PubMed ID: 27907897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICSI does not increase the cumulative live birth rate in non-male factor infertility.
    Li Z; Wang AY; Bowman M; Hammarberg K; Farquhar C; Johnson L; Safi N; Sullivan EA
    Hum Reprod; 2018 Jul; 33(7):1322-1330. PubMed ID: 29897449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of endometrial scratching before the second IVF/ICSI treatment: a cost-effectiveness analysis of a randomized controlled trial (SCRaTCH trial).
    van Hoogenhuijze NE; van Eekelen R; Mol F; Schipper I; Groenewoud ER; Traas MAF; Janssen CAH; Teklenburg G; de Bruin JP; van Oppenraaij RHF; Maas JWM; Moll E; Fleischer K; van Hooff MHA; de Koning CH; Cantineau AEP; Lambalk CB; Verberg M; van Heusden AM; Manger AP; van Rumste MME; van der Voet LF; Pieterse QD; Visser J; Brinkhuis EA; den Hartog JE; Glas MW; Klijn NF; van der Zanden M; Bandell ML; Boxmeer JC; van Disseldorp J; Smeenk J; van Wely M; Eijkemans MJC; Torrance HL; Broekmans FJM
    Hum Reprod; 2022 Jan; 37(2):254-263. PubMed ID: 34864993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prioritizing IVF treatment in the post-COVID 19 era: a predictive modelling study based on UK national data.
    Bhattacharya S; Maheshwari A; Ratna MB; van Eekelen R; Mol BW; McLernon DJ
    Hum Reprod; 2021 Feb; 36(3):666-675. PubMed ID: 33226080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the chances of having a baby with or without treatment at different time points in couples with unexplained subfertility.
    McLernon DJ; Lee AJ; Maheshwari A; van Eekelen R; van Geloven N; Putter H; Eijkemans MJ; van der Steeg JW; van der Veen F; Steyerberg EW; Mol BW; Bhattacharya S
    Hum Reprod; 2019 Jun; 34(6):1126-1138. PubMed ID: 31119290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IVF for unexplained subfertility; whom should we treat?
    van Eekelen R; van Geloven N; van Wely M; Bhattacharya S; van der Veen F; Eijkemans MJ; McLernon DJ
    Hum Reprod; 2019 Jul; 34(7):1249-1259. PubMed ID: 31194864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the prognosis for a live birth after unexplained recurrent implantation failure following IVF/ICSI?
    Koot YEM; Hviid Saxtorph M; Goddijn M; de Bever S; Eijkemans MJC; Wely MV; van der Veen F; Fauser BCJM; Macklon NS
    Hum Reprod; 2019 Oct; 34(10):2044-2052. PubMed ID: 31621857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IVF or IUI as first-line treatment in unexplained subfertility: the conundrum of treatment selection markers.
    Tjon-Kon-Fat RI; Tajik P; Zafarmand MH; Bensdorp AJ; Bossuyt PMM; Oosterhuis GJE; van Golde R; Repping S; Lambers MDA; Slappendel E; Perquin D; Pelinck MJ; Gianotten J; Maas JWM; Eijkemans MJC; van der Veen F; Mol BW; van Wely M;
    Hum Reprod; 2017 May; 32(5):1028-1032. PubMed ID: 28333222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of models for predicting cumulative live birth over multiple complete cycles of IVF treatment.
    Ratna MB; Bhattacharya S; McLernon DJ
    Hum Reprod; 2023 Oct; 38(10):1998-2010. PubMed ID: 37632223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; McLernon DJ; Bhattacharya S; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2018 Sep; 33(9):1684-1695. PubMed ID: 30085143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy chances on an IVF/ICSI waiting list: a national prospective cohort study.
    Eijkemans MJ; Lintsen AM; Hunault CC; Bouwmans CA; Hakkaart L; Braat DD; Habbema JD
    Hum Reprod; 2008 Jul; 23(7):1627-32. PubMed ID: 18456667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ICSI in IVF cycles in women with tubal ligation does not improve pregnancy or live birth rates.
    Grimstad FW; Nangia AK; Luke B; Stern JE; Mak W
    Hum Reprod; 2016 Dec; 31(12):2750-2755. PubMed ID: 27738114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative live birth rates following miscarriage in an initial complete cycle of IVF: a retrospective cohort study of 112 549 women.
    Cameron NJ; Bhattacharya S; Bhattacharya S; McLernon DJ
    Hum Reprod; 2017 Nov; 32(11):2287-2297. PubMed ID: 29040570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.